作者
F Asghari, N Haghnavaz, B Baradaran, M Hemmatzadeh, T Kazemi
发表日期
2016/7/1
来源
Biomedicine & Pharmacotherapy
卷号
81
页码范围
305-317
出版商
Elsevier Masson
简介
Breast cancer is the most common type of cancer in women whose prevalence is increasing every year. Common strategies for diagnosis, prognosis and specific treatment of breast cancer need improvements to increase patients’ survival. For this reason, there is growing number of efforts world-wide with molecular approaches. With the advent of microRNAs (miRNAs), they have been interested for almost all aspects of tumorgenesis and correlation of breast cancer and microRNAs was discovered for the first time in 2005. MiRNAs form a group of small noncoding RNAs which participate in regulation of gene expression and subsequently several biological processes and pathogenesis of various diseases. As other cancers, miRNAs involved in breast cancer are classified in two groups: the first group is tumor inducing miRNAs (also called oncomirs) that can induce tumor initiation and progression, and their …
引用总数
2016201720182019202020212022202320247510547113
学术搜索中的文章